Bill > HR4065

This bill, the Chronic Kidney Disease Improvement in Research and Treatment Act of 2021, aims to improve the understanding of and access to treatment for chronic kidney disease. Key provisions include: - Expanding the Medicare annual wellness benefit to include kidney disease screening. - Increasing access to the Medicare kidney disease education benefit by allowing renal dialysis facilities to provide these services. - Requiring studies on increasing kidney transplantation rates and understanding the progression of kidney disease in minority populations. - Refining the end-stage renal disease payment system to improve accuracy and support new therapies. - Consolidating and modernizing quality programs for end-stage renal disease to improve patient decision-making and transparency. - Providing guaranteed access to Medigap coverage for Medicare beneficiaries with end-stage renal disease and allowing individuals with kidney failure to retain access to private insurance.

Business and Industry, Health and Social Services

https://www.congress.gov/bill/117th-congress/house-bill/4065/all-info